Investigation of antifungal susceptibility of Aspergillus species isolated from systemic clinical specimens by different methods

被引:0
|
作者
Korkmaz, Emine [1 ]
Ergon, M. Cem [1 ]
机构
[1] Dokuz Eylul Univ, Fac Med, Dept Med Microbiol, TR-35340 Izmir, Turkiye
关键词
Aspergillus; Antifungal susceptibility; Broth microdilution; Gradient diffusion test; Disk diffusion; BROTH MICRODILUTION; AMPHOTERICIN-B; TESTING SUSCEPTIBILITIES; ETEST; ITRACONAZOLE; DIFFUSION; SPP; POSACONAZOLE; VORICONAZOLE; AGENTS;
D O I
10.1016/j.ijmmb.2024.100642
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Due to the potential for Aspergillus species to cause lethal infections and the rising rates of antifungal resistance, the significance of antifungal susceptibility tests has increased. We aimed to assess the sensitivities of Aspergillus species to amphotericin B (AMB), voriconazole (VOR), itraconazole (ITZ), and caspofungin (CAS) using disk diffusion (DD) and gradient diffusion (GD) methods and compare them with broth microdilution (BMD) as the reference susceptibility method. Methods: The study involved 62 Aspergillus fumigatus, 28 Aspergillus flavus, and 16 Aspergillus terreus isolates, totaling 106 Aspergillus isolates. BMD and DD methods were performed in accordance with CLSI M38-A2 and CLSI M51-A documents, respectively. The GD method utilized nonsupplemented Mueller Hinton agar (MHA) as the medium. Results: In the BMD method, the lowest minimal inhibitory concentration (MIC)90 or minimal effective concentration (MEC)90 values were observed for VOR and CAS (0.5 mu g/mL and 0.06 mu g/mL, respectively). AMB and ITZ MIC90 values were both 2 mu g/mL. In our comparison of the GD method with the BMD method at +/- 2 dilution, we observed essential agreement rates of 91.6%, 99.1%, 100%, and 38.6% for AMB, VOR, ITZ, and CAS, respectively. When comparing DD and BMD methods, we found categorical agreement rates of 65.1%, 99.1%, 77.3%, and 100% for AMB, VOR, ITZ, and CAS, respectively. For GD and BMD methods, these rates were 79.2%, 99.1%, 87.8%, and 100%. Conclusions: Given the high essential and categorical agreement rates, we posit that the GD method is a viable alternative to the BMD method for AMB, ITZ and VOR but not for CAS. In addition, the use of nonsupplemented MHA in the GD method proves advantageous due to its cost-effectiveness and widespread availability compared to other growth media.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Antifungal susceptibility profile of cryptic species of Aspergillus isolated from clinical samples
    Alastruey-Izquierdo, A.
    [J]. MYCOSES, 2015, 58 : 18 - 18
  • [2] Antifungal Susceptibility of Saccharomyces cerevisiae Isolated from Clinical Specimens
    Gorzynska, Aleksandra
    Kondracka, Kamila
    Korzeniowska-Kowal, Agnieszka
    Nawrot, Urszula
    [J]. PATHOGENS, 2024, 13 (03):
  • [3] Species distribution and antifungal susceptibility patterns of Aspergillus isolates from clinical specimens and soil samples in Mexico
    Trevino-Rangel, Rogelio de J.
    Villanueva-Lozano, Hiram
    Bonifaz, Alexandro
    Castanon-Olivares, Laura R.
    Andrade, Angel
    Becerril-Garcia, Miguel A.
    Martinez-Resendez, Michel F.
    Ayala-Gaytan, Jacobo
    Montoya, Alexandra M.
    Gonzalez, Gloria M.
    [J]. MEDICAL MYCOLOGY, 2021, 59 (10) : 1006 - 1014
  • [4] Investigation of the susceptibility of Candida species isolated from denture wearers to different antifungal antibiotics
    Abaci, Ozlem
    Haliki-Uztan, Alev
    [J]. AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2011, 5 (12): : 1398 - 1403
  • [5] Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan
    Toyotome, Takahito
    Saito, Shunpei
    Koshizaki, Yusuke
    Komatsu, Ryoichi
    Matsuzawa, Tetsuhiro
    Yaguchi, Takashi
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (02) : 321 - 323
  • [6] Antifungal susceptibility of the Aspergillus species by CLSI reference methods
    Altinbas, R.
    Ozakkas, F.
    Sav, H.
    Akkoyun, E.
    Turan, D.
    Baris, A.
    Kiraz, N.
    [J]. MYCOSES, 2015, 58 : 73 - 73
  • [7] Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillus nidulans complex and Aspergillus terreus complex isolated from clinical specimens
    Mohamadnia, A.
    Salehi, Z.
    Namvar, Z.
    Tabarsi, P.
    Pourabdollah-Toutkaboni, M.
    Rezaie, S.
    Marjani, M.
    Moniri, A.
    Abtahian, Z.
    Mahdaviani, S. A.
    Mortezaee, V
    Askari, E.
    Sharifynia, S.
    [J]. JOURNAL DE MYCOLOGIE MEDICALE, 2020, 30 (03):
  • [8] Antifungal susceptibility of molecularly confirmed Aspergillus species from clinical samples
    Tzar, Mohd Nizam
    Mustakim, Sahlawati
    Yusoff, Hamidah
    Tap, Ratna Mohd
    [J]. MALAYSIAN JOURNAL OF PATHOLOGY, 2024, 46 (01) : 71 - 78
  • [9] Molecular epidemiology and antifungal susceptibility of Aspergillus species isolated from asthma patients
    Hedayati, M. T.
    Vakili, M.
    Mortezaei, V.
    Mahdaviani, S. A.
    Mirenayat, M. S.
    Pourabdollah, M.
    Heshmatnia, J.
    Fakharian, A.
    Pourdolat, G.
    Sharifynia, S.
    Alialy, M.
    Abastabar, M.
    Charati, J. Yazdani
    [J]. MEDICAL MYCOLOGY, 2018, 56 : S34 - S34
  • [10] Prevalence and in vitro antifungal susceptibility of cryptic species of the genus Aspergillus isolated in clinical samples
    Reyes Vidal-Acuna, Maria
    Ruiz, Maite
    Jose Torres, Maria
    Aznar, Javier
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (05): : 296 - 300